Similarly, the downregulation of AKT1 has been shown to enhance the chemosensitivity of multiple tumor cells, including non-small-cell lung cancer, esophageal squamous cell carcinoma, and head and neck squamous cell carcinoma [17–19]. Here, AKT1 is linked to head and neck squamous cell carcinoma.